مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Cancer risk of heterozygotes with the NBN founder mutation.
Normal view MARC view ISBD view

Cancer risk of heterozygotes with the NBN founder mutation. [electronic resource]

By:
  • Seemanová, Eva
Contributor(s):
  • Jarolim, Petr
  • Seeman, Pavel
  • Varon, Raymonda
  • Digweed, Martin
  • Swift, Michael
  • Sperling, Karl
Producer: 20071227Description: 1875-80 p. digitalISSN:
  • 1460-2105
Subject(s):
  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms -- epidemiology
  • Cell Cycle Proteins -- genetics
  • Chromosome Breakage
  • Colorectal Neoplasms -- epidemiology
  • Czech Republic -- epidemiology
  • DNA Mutational Analysis
  • Female
  • Founder Effect
  • Gene Deletion
  • Genetic Carrier Screening
  • Genetic Predisposition to Disease
  • Genital Neoplasms, Female -- epidemiology
  • Germ-Line Mutation
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Neoplasms -- epidemiology
  • Nijmegen Breakage Syndrome -- epidemiology
  • Nuclear Proteins -- genetics
  • Odds Ratio
  • Research Design
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Slovakia -- epidemiology
  • Stomach Neoplasms -- epidemiology
Online resources:
  • Available from publisher's website
In: Journal of the National Cancer Institute vol. 99
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

Log in to your account to post a comment.

Cancer risk of heterozygotes with the NBN founder mutation.

APA

Seemanová E., Jarolim P., Seeman P., Varon R., Digweed M., Swift M. & Sperling K. (20071227). Cancer risk of heterozygotes with the NBN founder mutation. : Journal of the National Cancer Institute.

Chicago

Seemanová Eva, Jarolim Petr, Seeman Pavel, Varon Raymonda, Digweed Martin, Swift Michael and Sperling Karl. 20071227. Cancer risk of heterozygotes with the NBN founder mutation. : Journal of the National Cancer Institute.

Harvard

Seemanová E., Jarolim P., Seeman P., Varon R., Digweed M., Swift M. and Sperling K. (20071227). Cancer risk of heterozygotes with the NBN founder mutation. : Journal of the National Cancer Institute.

MLA

Seemanová Eva, Jarolim Petr, Seeman Pavel, Varon Raymonda, Digweed Martin, Swift Michael and Sperling Karl. Cancer risk of heterozygotes with the NBN founder mutation. : Journal of the National Cancer Institute. 20071227.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site